Dr. Daniela Hozbor’s decision to travel 400 kilometres from Mar del Plata to study biochemistry at the National University of La Plata set in motion a career that now addresses one of infectious disease’s most pressing challenges. Today, her molecular-level investigations directly inform global pertussis vaccine development strategies.
The statistics underscore the urgency of her work: pertussis causes approximately 24.1 million cases annually worldwide, with 160,700 deaths per year—85 percent occurring in infants under one year of age. These figures highlight critical gaps in current vaccine effectiveness, particularly in vulnerable populations. Hozbor’s research focuses on identifying and addressing these molecular-level inefficiencies to enhance immunisation outcomes. Her work demonstrates how targeted scientific investigation can translate epidemiological data into improved prevention mechanisms, ultimately reducing the burden of whooping cough globally.
Read the full article on GMJ Newsroom.
Was this article helpful?
